23. Roden M, Merker L, Christiansen AV, Roux F, Salsali A, Kim G, EMPA-REG EXTEND™ MONO investigators, et al. Safety, tolerability and effects on cardiometabolic risk factors of empagliflozin monotherapy in drug-naïve patients with type 2 diabetes: a double-blind extension of a ...